SCHEMBL2223943

SCHEMBL2223943

COc1ncc(C)cc1S(=O)(=O)c1ccc(C)c(NC2CCN(C)CC2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 6/20 0.47
DRD2 P14416 2/20 0.47
SLC6A2 P23975 2/20 0.47
HTR2A P28223 2/20 0.47
HTR2C P28335 2/20 0.47
HTR7 P34969 2/20 0.47
HRH1 P35367 2/20 0.47
ADRA1B P35368 2/20 0.47
SLC6A3 Q01959 2/20 0.47
SSTR4 P31391 6/20 0.43
CYP2D6 P10635 4/20 0.43
KCNH2 Q12809 2/20 0.43
SLC6A4 P31645 1/20 0.43
CCR6 P51684 1/20 0.42
LCK P06239 1/20 0.38
PIK3CD O00329 1/20 0.37
BRD4 O60885 2/20 0.37
HTR6 P50406 1/20 0.37
PIK3R1 P27986 1/20 0.36
PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16986613 0.78 CYP3A4 (0.49) CYP3A4DRD2SLC6A2HTR2AHTR2C
Hydrochloric Acid SCHEMBL2224225 0.77 CYP3A4 (0.49) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL2222873 0.76 CYP3A4 (0.50) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL2223312 0.74 MAPT (0.56) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL2222827 0.73 DRD2 (0.41) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL4629547 0.72 CA2 (0.45) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL2223330 0.71 CYP3A4 (0.53) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL16986591 0.70 KCNH2 (0.64) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL2223601 0.70 CYP3A4 (0.55) CYP3A4DRD2SLC6A2HTR2AHTR2C
SCHEMBL2269860 0.70 CYP3A4 (0.54) CYP3A4DRD2SLC6A2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP claimed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO claimed
US-9018231-B2 Sulfone compounds as 5-HT6 receptor ligands SUVEN LIFE SCIENCES LIMITED (IN) 2015-04-28 US disclosed
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2013-01-03 US disclosed
EP-2521714-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS Suven Life Sciences Limited (IN) 2012-11-14 EP disclosed
WO-2011083487-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2011-07-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130005709-A1 SULFONE COMPOUNDS AS 5-HT6 RECEPTOR LIGANDS HTR6, HTR5A, HTR1A CYP3A4 138/4885DRD2 210/4885SLC6A2 34/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.